Latest News | Lupin Inks Pact to Market Pegfilgrastim in Brazil

New Delhi, Dec 3 (PTI) Drug maker Lupin on Friday said it has inked a marketing pact with Biomm SA to distribute and market biosimilar Pegfilgrastim in Brazil.

The company has entered into an exclusive distribution and marketing agreement with Biomm SA in Brazil for distribution of Pegfilgrastim, Lupin said in a statement.

Also Read | Xiaomi 11T Pro Reportedly Spotted on Bluetooth SIG Certification Site, India Launch Soon.

The Mumbai-based drug maker had earlier received approval from the US Food and Drug Administration (USFDA) for the product.

Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy.

Also Read | Oppo Pad Tablet With Snapdragon 870 SoC Tipped To Debut in India Next Year: Report.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)